WARRANTS - Additional information (Details) |
1 Months Ended | 12 Months Ended |
|---|---|---|
|
Apr. 30, 2023
$ / shares
shares
|
Dec. 31, 2023
USD ($)
$ / shares
shares
|
|
| Exercise Price 28.80 | ||
| WARRANTS | ||
| Number of warrants expired | shares | 100,073 | |
| Exercise Price | $ / shares | $ 28.80 | |
| Pre- funded warrants | ||
| WARRANTS | ||
| Number of warrants exercised | shares | 360,000 | |
| Exercise Price | $ / shares | $ 0.01 | |
| Proceeds from issuance of warrants net of issuance costs | $ | $ 3,600 |
| X | ||||||||||
- Definition Number of warrants or rights exercised. No definition available.
|
| X | ||||||||||
- Definition Number of warrants or rights expired. No definition available.
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt) net of issuance costs. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|